Anti-VEGF therapy for choroidal neovascularisation previously treated with photodynamic therapy

被引：0
|
作者：
S Jyothi
H R Chowdhury
V Chong
S Sivaprasad
机构：
[1] Laser and Retinal Research Unit,Department of Ophthalmology
[2] King's College Hospital,undefined
[3] Denmark Hill,undefined
[4] London,undefined
[5] UK,undefined
来源：
Eye | 2010年 / 24卷
关键词：
choroidal neovascularisation; bevacizumab; ranibizumab; photodynamic therapy; anti-VEGF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1018 / 1023
页数：5
相关论文
共 50 条
  • [1] Anti-VEGF therapy for choroidal neovascularisation previously treated with photodynamic therapy
    Jyothi, S.
    Chowdhury, H. R.
    Chong, V.
    Sivaprasad, S.
    EYE, 2010, 24 (06) : 1018 - 1023
  • [2] Optimising the management of choroidal neovascularisation in Asian patients: consensus on treatment recommendations for anti-VEGF therapy
    Koh, A.
    Lim, T. H.
    Eong, Au K. G.
    Chee, C.
    Ong, S. G.
    Tan, N.
    Yeo, I
    Wong, D.
    SINGAPORE MEDICAL JOURNAL, 2011, 52 (04) : 232 - 240
  • [3] Photodynamic and Anti-VEGF Therapy for Polypoidal Choroidal Vasculopathy - 'Real World' Outcomes in a Caucasian Population
    Gilmour, Kenneth M.
    Young, David
    Jamison, Aaron
    Precup, Monica
    Gilmour, David F.
    OPEN OPHTHALMOLOGY JOURNAL, 2023, 17
  • [4] INTRAVITREAL ANTI-VEGF VERSUS PHOTODYNAMIC THERAPY WITH VERTEPORFIN FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION
    Yoon, Jong Uk
    Byun, Yeo Jue
    Koh, Hyoung Jun
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (03): : 418 - 424
  • [5] Impact of photodynamic therapy combined with Anti-VEGF vs. Anti-VEGF monotherapy on choriocapillaris vessel density in polypoidal choroidal vasculopathy
    Kuo, Po-Chin
    Hsu, Sheng-Min
    Huang, Yi-Hsun
    Chang, Chun-Hsiang
    Chang, Yi-Sheng
    Hung, Jia-Horung
    Lai, Chun-Chieh
    Lee, Yu-Kuei
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2025, 52
  • [6] Management of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy
    Kelvin Yi Chong Teo
    Wei Yan Ng
    Shu Yen Lee
    Chui Ming Gemmy Cheung
    Drugs, 2016, 76 : 1119 - 1133
  • [7] Intravitreal anti-VEGF therapy for choroidal neovascularisation secondary to pathological myopia: 4-year outcome
    Ruiz-Moreno, Jose M.
    Arias, Luis
    Montero, Javier A.
    Carneiro, Angela
    Silva, Rufino
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (11) : 1447 - 1450
  • [8] Effects of VEGF levels on anti-VEGF therapy for patients with idiopathic choroidal neovascularization
    Fan, Xiaojuan
    Gao, Ning
    Li, Jingming
    Lei, Jianqin
    Kang, Qianyan
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2018, 441 (1-2) : 173 - 179
  • [9] Anti-VEGF Therapy in Myopic Choroidal Neovascularization: Long-Term Results
    Freitas-da-Costa, Paulo
    Pinheiro-Costa, Joao
    Carvalho, Beatriz
    Falcao, Manuel
    Brandao, Elisete
    Falcao-Reis, Fernando
    Carneiro, Angela
    OPHTHALMOLOGICA, 2014, 232 (01) : 57 - 63
  • [10] Effects of oral bisphosphonates on myopic choroidal neovascularisation over 2 years of follow-up: comparison with anti-VEGF therapy and photodynamic therapy. A pilot study
    Miki, Akiko
    Honda, Shigeru
    Nagai, Takayuki
    Tsukahara, Yasutomo
    Negi, Akira
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (06) : 770 - 774
12345